Importance of patient selection in the use of intermittent inotrope infusions for advanced heart failure

Congestive Heart Failure

Volumn 5, Issue 2, 1999, Pages 86-90

  Oren, R M ^a   Cotts, W G ^a   Pies, C J ^a   Duncan, M L ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIURETIC AGENT; ENALAPRIL; ENALAPRIL MALEATE; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INOTROPIC AGENT; ISOSORBIDE DINITRATE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT; WARFARIN;

AGED; CARDIOVASCULAR DISEASE; CASE REPORT; CONGESTIVE HEART FAILURE; DRUG INFUSION; DRUG INTERMITTENT THERAPY; FEMALE; HEART FAILURE; HEMODYNAMIC MONITORING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRACTICE GUIDELINE; REVIEW; TREATMENT INDICATION;

EID: 0032967590     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)